75 patients randomized in Part B of study to receive either intranasal betahistine or placeboTop-line results from the trial expected…
LONDON and BELFAST, UK / ACCESSWIRE / February 14, 2022 / (CSE:POKO) - Poko Innovations Inc., an award-winning international UK…
STOCKHOLM, SE / ACCESSWIRE / February 14, 2022 / iZafe Group (STO:IZAFE-B)iZafe Group AB (publ) - announces that in connection…
FT. MYERS, FL / ACCESSWIRE / February 14, 2022 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing…
Insurer is the first in Canada to offer health and medical monitoring through Cloud DX to its individual life critical…
Seasoned executive with more than 20 years of professional medical practice management to lead ongoing success and expansion of The…
ST. LOUIS, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for…
BOSTON, Feb. 14, 2022 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to defeating cancer…
Led by W.T.T. Investment, the family office of Taiwan’s Tsai familyProceeds to Advance Clinical Studies of its Potential First-in-Class Therapeutic…
Phase 1 therapeutic trial for PNT6555, the lead of the pan-cancer PNT2004 fibroblast activation protein-alpha (FAP-alpha) inhibitor program, planned for…